River Global Investors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,662
Closed -$611K 167
2024
Q1
$611K Buy
7,662
+4,354
+132% +$333K 0.15% 163
2023
Q4
$261K Buy
+3,308
New +$235K 0.05% 216
2020
Q4
Sell
-90,216
Closed -$5.27M 138
2020
Q3
$5.27M Sell
90,216
-4,660
-5% -$290K 0.39% 75
2020
Q2
$6.16M Sell
94,876
-11,842
-11% -$746K 0.45% 60
2020
Q1
$6.34M Sell
106,718
-73,188
-41% -$4.89M 0.58% 43
2019
Q4
$13.4M Buy
179,906
+25,060
+16% +$1.76M 0.74% 35
2019
Q3
$9.77M Buy
154,846
+274
+0.2% +$16.2K 0.69% 43
2019
Q2
$8.43M Buy
154,572
+23,061
+18% +$1.24M 0.59% 52
2019
Q1
$7.09M Buy
131,511
+68,020
+107% +$4.2M 0.5% 69
2018
Q4
$4.16M Buy
+63,491
New +$4.74M 0.36% 94

Other funds holding CVS

River Global Investors's CVS Position: Q2 2024 in Review

River Global Investors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 7,662 shares — an estimated $611K sold.

River Global Investors first reported a position in CVS in Q4 2018 and held it in 10 quarters. The position peaked at $13.4M in Q4 2019. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • River Global Investors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • River Global Investors sold 7,662 CVS Health shares in Q2 2024, an estimated $611K.
  • River Global Investors first reported a position in CVS Health in Q4 2018 and held it in 10 quarters.
  • River Global Investors's CVS Health position peaked at $13.4M in Q4 2019.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on River Global Investors's 13F filing for Q2 2024, filed 12 Aug 2024.